Innoviva, Inc. (INVA)
20.00
+0.25
(+1.27%)
USD |
NASDAQ |
Jan 30, 16:00
20.00
0.00 (0.00%)
After-Hours: 20:00
Innoviva Market Cap : 1.495B for Jan. 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 273.69B |
| Pfizer Inc. | 150.33B |
| Bristol Myers Squibb Co. | 112.07B |
| Nektar Therapeutics | 645.83M |
| Oramed Pharmaceuticals, Inc. | 134.13M |
Market Cap Related Metrics
| PE Ratio | 14.35 |
| PS Ratio | 3.931 |
| PEG Ratio | 0.1398 |
| Price to Book Value | 1.481 |
| Price to Free Cash Flow | 8.048 |
| Price | 20.00 |
| Earnings Yield | 6.97% |
| PEGY Ratio | 0.1398 |
| Operating PE Ratio | 9.420 |
| Normalized PE Ratio | 11.61 |